Medway NHS Foundation Trust

The Medway NHS Foundation Trust incorporates Medway Maritime Hospital in Gillingham, Kent https://www.medway.nhs.uk/

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site MRI liver facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Age Specific Genetic Testing for Lynch Syndrome
  • Oncology services:
    • On-site chemotherapy services
  • Surgical services:
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT

Data Quality
All Patients: Trust Network National
Number of patients in Audit 155 1013 31676
Case ascertainment (%) 79 93 95
Data completeness of:
– Pre-treatment TNM (%) 72 78 80
– Performance status (%) 90 91 86
Patients having major resection: Trust Network National
Number of patients in Audit 110 641 19218
ASA grade 1 (%) 17 9 11
ASA grade 2 (%) 53 52 53
ASA grade 3 (%) 20 28 28
ASA grade 4+ (%) N/A 1 3
ASA grade not recorded (%) 10 10 5
Data completeness of:
7 Audit items for risk-adjustment (%) 69 81 86

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 155 1013 31676
Seen by Clinical Nurse Specialist (%) 91 86 87
All patients deemed potentially curative Trust Network National
Number of potentially curative patients 29 234 7416
Undergoing major resection (%) 93 83 86

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 110 641 19218
Distant metastases (%) 20 10 8
Urgent or emergency surgery (%) 20 19 15
At least 12 lymph nodes excised (%) 79 80 84
Laparoscopic surgery attempted (%) 77 70 69
Risk-adjusted length of stay > 5 days (%) 51 57 62
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 88 454 11837
Adjuvant chemotherapy (%) 69 64 62

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 18 127 4588
Neoadjuvant therapy (%) 31 22 33
Circumferential resection margin: Recorded (%) 89 95 90
Circumferential resection margin: Negative (%) 78 54 80
Rectal volume N/A N/A N/A
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate N/A N/A N/A
APER/Hartmanns (%) N/A N/A N/A

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd